Hire an Advanced Robo-Advisor to Trade MYL on Your Behalf.
- Street Sentiment
- Personalized Strategy
- Free Trading Simulator
Course of Action
Sentiment (10 days)
- Strong Buy
- Strong Sell
DAILY PRICE CHANGE VS SENTIMENT
What is Robo investing?
Smart Auto-Trading is an advanced Robo-Trader designed to provides investors with a a state of the art automated trading tool to trade the S&P 500. Its robo is designed to screen, monitor and auto-trade elite stocks like MYLAN N.V. (MYL). It's Artificial Intelligence augments your potential for profit while eliminating most of the work traditionally involved in trading stocks.
What is Smart Auto-Trading good for?
If you are interested in systematic, active investing, Smart Auto-Trading can be a great alternative to passive index funds and ETFs. Smart Auto-Trading uses Artificial Intelligence concepts to screen, monitor and auto-trade stocks. Used in a tax-deferred account such as an IRA, SIMPLE IRA, Rollover IRA, Keogh, 529 College Plan or UGMA it auto-trades systematically using your carefully defined strategy. Using Smart Auto-Trading is like having a professional trader working for you. You turn it on and it just works.
Smart Auto-Trading actively trades the S&P 500 day-in and day-out in your account while you attend more important life events. Because of the systematic nature of Smart Auto-Trading, your account has the potential to grow at a faster rate than if you were to use a passive investment vehicle such as an index fund or ETF. Systematic active trading using Artificial Intelligence holds the potential to grow your account faster.
Using Smart Auto-Trading is Easy
To connect Smart Auto-Trading to your account you will need to open an account with Ally Invest, one of the most trusted broker/dealer in the United States. Ally Invest is the brokerage firm Stock Circles uses to auto-trade. It offers a very competitive price per trade and flawless execution.
To open an account, please go to Ally Invest's account opening page is available at: https://invest.ally.com/ola/
Once the account is open, you are ready to transfer your money into the newly opened account. To do so, you will need to send a copy of your 401K or other account statement to Ally Invest as well as transfer instructions to email@example.com. Once they receive your instructions, a Customer Support specialist will help you complete the transfer.
After a few business days, the account will be funded and you will be ready to auto-trade using Smart Auto-Trading.
While this is in progress, you might want to test your strategy in simulation mode free of charge at stockcircles.com. Doing so will help you get comfortable with the product's benefits.
There are clear benefits associated with using a Robo-Trader such as Smart Auto-Trading to help you reach your financial goals. Smart Auto-Trading simplifies stock investing down to a few easy steps. It auto-trades for you, using your personalized strategy, while you attend more important life events.
Using Smart Auto-Trading is like having thousands of traders working for you to help you reach your financial goals.
Smart Auto-Trading actively trades which is different from passive investing. The robo is on the lookout, working to maximize your potential every business day of the year. It trades on the news taking advantage of price changes and trends by listening into trader's communications and by validating this information with market data.
Smart Auto-Trading is one of the first robo-Trader to take advantage of Government grade listening technology, Artificial Intelligence, social media and market data natively.
Try Smart Auto-Trading today!
You can test Smart Auto-Trading in simulation mode, risk free, Stock Circles today.
Disclaimer: Past performance may not be indicative of future results. Therefore, you should assume that the future performance of any specific investment, investment strategy (including robo-strategies), or product made in reference directly or indirectly on this website, will be profitable or equal to corresponding indicated performance levels. Robot-Traders like other investment methods rely on favorable market conditions to provide positive outcomes.
MYLAN N.V. (MYL) News
Mylan Partners with Fujifilm Kyowa Kirin Biologics to Commercialize Biosimilar to Humira
April 11, 2018 -- Global pharmaceutical company Mylan N.V. (NASDAQ: MYL) today announced it is partnering with Fujifilm Kyowa Kirin Biologics Co., Ltd. to commercialize a biosimilar to Humira® (adalimumab) developed by Fujifilm Kyowa Kirin Biologics. Through the partnership agreement, Mylan will leverage its regulatory platform to seek approval and commercialize the product in Europe.
Humira is a TNF-inhibitor1 aimed at treating multiple chronic inflammatory conditions. The product is indicated in Europe for the treatment of rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa and uveitis. Humira is the world's best-selling biologic medication and had brand sales of approximately $4.1 billion in Europe for the 12 months ending Dec. 31, 2017, according to IQVIA.
The European Medicines Agency (EMA) accepted for review the Marketing Authorisation Application for its proposed biosimilar to Humira on May 18, 2017. The companies expect to receive a decision from EMA in the second half of 2018.
Under the terms of the agreement between two companies, Fujifilm Kyowa Kirin Biologics grants Mylan an exclusive license to commercialize the adalimumab biosimilar in Europe and will receive an up-front fee. In addition, Fujifilm Kyowa Kirin Biologics is eligible to receive a subsequent commercialization milestone payment and sales royalties. Mylan will be responsible for the sales activity of the product in European countries. The two companies continue to negotiate for commercializing the product in additional territories. In addition, Mylan's partner Biocon will receive economic benefit through this collaboration.Get Started today! - Risk Free